Clinical Trial Update: Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a generative AI chatbot to help with anxiety and depression in people with cannabis use disorder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Cannabis Use Disorder
• Major Depressive Disorder

Snippet

Sponsor: Trustees of Dartmouth College | Conditions: Cannabis Use Disorder, Anxiety | Phase 1 | Status: RECRUITING